Primaquine for plasmodium vivax malaria treatment – authors' reply
Príomhchruthaitheoirí: | Price, RN, Taylor, WRJ, Thriemer, K, White, NJ, Day, NP |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2020
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
de réir: Setyadi, A, et al.
Foilsithe / Cruthaithe: (2019) -
Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria
de réir: Watson, JA, et al.
Foilsithe / Cruthaithe: (2022) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
de réir: Taylor, WRJ, et al.
Foilsithe / Cruthaithe: (2023) -
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
de réir: Thriemer, K, et al.
Foilsithe / Cruthaithe: (2020) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
de réir: Luzzi, G, et al.
Foilsithe / Cruthaithe: (1992)